Does CARFILZOMIB Cause Lymphopenia? 175 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Lymphopenia have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.8% of all adverse event reports for CARFILZOMIB.
175
Reports of Lymphopenia with CARFILZOMIB
0.8%
of all CARFILZOMIB reports
44
Deaths
43
Hospitalizations
How Dangerous Is Lymphopenia From CARFILZOMIB?
Of the 175 reports, 44 (25.1%) resulted in death, 43 (24.6%) required hospitalization, and 31 (17.7%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
Yes, Lymphopenia is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which CARFILZOMIB Alternatives Have Lower Lymphopenia Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL